OXY 50

Oxymetholone Tablets

PRODUCT NAME & PACKAGING

Brand Name: OXY 50
Generic Name: Oxymetholone
Strength & Packaging: 50 tablets per tub | 50 mg per tablet

OXY 50 is an oral anabolic steroid tablet formulation containing 50 mg of oxymetholone per tablet. In archived FDA labeling, oxymetholone 50 mg tablets were marketed as ANADROL-50; the 50-count tub in your listing can be presented as a manufacturer-specific packaging format.

DESCRIPTION

Oxymetholone is described in FDA labeling as a potent anabolic and androgenic drug for oral administration. As an anabolic steroid, it belongs to the class of synthetic derivatives of testosterone.

INDICATIONS

Archived FDA labeling states that oxymetholone is indicated for the treatment of anemias caused by deficient red cell production, including acquired aplastic anemia, congenital aplastic anemia, myelofibrosis, and hypoplastic anemias associated with myelotoxic drugs. The same label notes that it should not replace other supportive measures such as transfusion, correction of iron or vitamin deficiencies, antibacterial therapy, or appropriate corticosteroid use.

DOSAGE & ADMINISTRATION

Route: Oral administration

Archived FDA labeling gives a recommended daily dose of 1 to 5 mg/kg/day in children and adults, with a usual effective dose of 1 to 2 mg/kg/day. Dose should be individualized, response may not be immediate, and a minimum trial of 3 to 6 months is recommended; some patients may later continue on a lower maintenance dose. For catalog presentation, this product should be described as for use only under the direction of a licensed healthcare professional.

MECHANISM OF ACTION

FDA labeling describes anabolic steroids as synthetic derivatives of testosterone that can improve nitrogen balance when adequate calories and protein are available. The label also states that oxymetholone enhances erythropoietin production and urinary excretion in patients with anemias due to bone marrow failure and often stimulates erythropoiesis in anemias caused by deficient red cell production.

PRECAUTIONS

Important precautions in archived FDA labeling include pregnancy, severe hepatic dysfunction, nephrosis or nephritic nephrosis, male breast or prostate carcinoma, and female breast carcinoma with hypercalcemia. The label also warns about serious class risks including peliosis hepatis, hepatic tumors, cholestatic hepatitis/jaundice, and blood lipid changes associated with increased atherosclerotic risk. Oxymetholone is also listed as a Schedule III controlled substance in the same labeling.

SIDE EFFECTS

Reported adverse reactions in archived FDA labeling include cholestatic jaundice, hepatic neoplasms, peliosis hepatis, nausea, vomiting, diarrhea, insomnia, gynecomastia, acne, edema, and libido changes. The label also lists androgen-related effects such as clitoral enlargement, menstrual irregularities, deepening of the voice, hirsutism, male-pattern hair loss, testicular atrophy, oligospermia, and premature epiphyseal closure in children.

STORAGE

Store at controlled room temperature: 20° to 25°C (68° to 77°F), with permitted excursions to 15° to 30°C (59° to 86°F).